Skip to main content
Erschienen in: Virology Journal 1/2017

Open Access 01.12.2017 | Research

Cyclophilin B facilitates the replication of Orf virus

verfasst von: Kui Zhao, Jida Li, Wenqi He, Deguang Song, Ximu Zhang, Di Zhang, Yanlong Zhou, Feng Gao

Erschienen in: Virology Journal | Ausgabe 1/2017

Abstract

Background

Viruses interact with host cellular factors to construct a more favourable environment for their efficient replication. Expression of cyclophilin B (CypB), a cellular peptidyl-prolyl cis-trans isomerase (PPIase), was found to be significantly up-regulated. Recently, a number of studies have shown that CypB is important in the replication of several viruses, including Japanese encephalitis virus (JEV), hepatitis C virus (HCV) and human papillomavirus type 16 (HPV 16). However, the function of cellular CypB in ORFV replication has not yet been explored.

Methods

Suppression subtractive hybridization (SSH) technique was applied to identify genes differentially expressed in the ORFV-infected MDBK cells at an early phase of infection. Cellular CypB was confirmed to be significantly up-regulated by quantitative reverse transcription-PCR (qRT-PCR) analysis and Western blotting. The role of CypB in ORFV infection was further determined using Cyclosporin A (CsA) and RNA interference (RNAi). Effect of CypB gene silencing on ORFV replication by 50% tissue culture infectious dose (TCID50) assay and qRT-PCR detection.

Results

In the present study, CypB was found to be significantly up-regulated in the ORFV-infected MDBK cells at an early phase of infection. Cyclosporin A (CsA) exhibited suppressive effects on ORFV replication through the inhibition of CypB. Silencing of CypB gene inhibited the replication of ORFV in MDBK cells. In conclusion, these data suggest that CypB is critical for the efficient replication of the ORFV genome.

Conclusions

Cellular CypB was confirmed to be significantly up-regulated in the ORFV-infected MDBK cells at an early phase of infection, which could effectively facilitate the replication of ORFV.
Abkürzungen
CsA
Cyclosporin A
CypB
Cyclophilin B
ESTs
Expressed sequence tags
EtBr
Ethidium bromide
FBS
Fetal bovine serum
HCV
Hepatitis C virus
HPV 16
Human papillomavirus type 16
JEV
Japanese encephalitis virus
MDBK
Madin―Darby bovine kidney cells
MEM
Minimal essential medium
MOI
Multiplicity of infection
mRNA
Messenger RNA
MTT
Tetrazolium salt 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide
ORFV
Orf virus
PBS
Phosphate buffered saline.
PPIase
Peptidyl-prolyl cis-trans isomerase
RNAi
RNA interference
SDS-PAGE
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis
TCID50
50% tissue culture infectious dose

Background

Orf virus (ORFV) is the type species of the genus Parapoxvirus, which has a worldwide distribution and is the causative agent of Orf, a contagious debilitating skin disease of sheep and goats also known as contagious ecthyma, contagious pustular dermatitis, infectious labial dermatitis, scabby mouth or sore mouth [1]. Primary infections are usually resolved within 1–2 months, however repeated and persistent infections can occur in the presence of an intensive inflammatory host antivirus immune response [2, 3]. The mechanisms that establish the repeated and persistent infections in vivo are almost completely unknown. Currently, the host immune response to ORFV has been extensively studied, yet many aspects of the complex host-virus interactions remain unclear.
Cyclophilins (Cyp) comprise a family of peptidyl-prolyl cis/trans isomerases, which are originally discovered as a cellular factor with high affinity for the immunosuppressant CsA [4, 5]. CypB is one of the most abundant members among the Cyp family, is ubiquitously expressed in most cells, and predominantly resides in the endoplasmic reticulum (ER) through the ER retention signal sequence in the C-terminus [6, 7]. CypB functions in various cellular processes, including transcriptional regulation, protein secretion, immune response and apoptosis [810]. In addition, some researchers have shown that many viruses such as Japanese encephalitis virus (JEV), hepatitis C virus (HCV) and human papillomavirus type 16 (HPV 16) require CypB for their replication [1113]. However, there has been no report on the involvement of CypB in the replication of ORFV.
In the present study, CypB was found to be significantly up-regulated in the ORFV-infected MDBK cells at an early phase of infection. However, the function of cellular CypB in ORFV replication has not yet been explored. Sequently, we investigated the role of CypB in the replication of ORFV in MDBK cells. Cyclosporin A (CsA) exhibited suppressive effects on ORFV replication through the inhibition of CypB. Silencing of CypB gene inhibited the replication of ORFV in MDBK cells. In conclusion, these data suggest that CypB is critical for the efficient replication of the ORFV genome.

Methods

Cells and virus

The Madin―Darby bovine kidney (MDBK) cells were maintained in minimal essential medium (MEM) (GIBCO, Invitrogen), supplemented with 10% fetal bovine serum (FBS) and penicillin (100 U/mL); streptomycin (100 mg/mL); and nystatin (20 mg/mL). The Orf virus used in this study (ORFV-Jilin) was isolated using MDBK cells from scab specimens collected from skin lesions of a 6-week-old small-tailed Han sheep afflicted with orf in November 2008 in the Jilin province of China [14].

Antibodies and reagents

The antibodies used in this study were anti-Cyclophilin B polyconal rabbit antibody (Abcam), PE-Cy5 conjugated rabbit anti-Cyclophilin B antibody (Bioss), anti-β-actin (Proteintech), Peroxidase-conjugated Affinipure Goat Anti-Mouse IgG (Proteintech) and Peroxidase-conjugated Affinipure Goat Anti-Rabbit IgG (Proteintech). CsA were purchased from Sigma. PolyATtract® mRNA Isolation Systems was purchased from Promega. PCR-Select™ cDNA Subtraction Kit and Advantage cDNA PCR Kit & Polymerase Mix were obtained from Clontech. X-treme GENE HP DNA Transfection Reagent and X-treme GENE siRNA Transfection Reagent were purchased from Roche.

Virus infection

MDBK cells have been reported to be least partially permissive for ORFV replication [14]. A confluent monolayer of MDBK cells cultured in 75-cm2 flasks were adsorbed with ORFV-Jilin (multiplicity of infection [MOI] = 3) for 2 h at 37 °C. After adsorption, unbound virus was removed by gentle washing with serum-free medium followed by the addition of fresh medium and further incubation at 37 °C. At 2 h after further incubation, ORFV transcripts were detected in MDBK cells infected with ORFV-Jilin. Thus, the starting point of early phase of ORFV infection was determined for 4 h. The cultures of incubated cells were harvested at 4 h post infection, and cell lysates were collected. Normal cell controls were collected in a similar manner. All samples were frozen in liquid nitrogen and stored at −80 °C until SSH library construction.

Construction and screening of Suppression subtractive hybridization (SSH) library

Total RNA was isolated from both mock- and ORFV-inoculated cell lysates using RNAiso Plus (Takara, Dalian, China) according to the manufacturer’s instructions. The quality of total RNA were determined by ultraviolet spectrophotometry (260 and 280 nm) and 1% agarose/ethidium bromide (EtBr) gel electrophoresis. Messenger RNA (mRNA) was isolated from total RNA using PolyATtract® mRNA Isolation Systems (Promega) according to the manufacturer’s instructions. The purified mRNA was treated with 1 mL of 75% ethanol and 0.1 volume of 3 mol/L NaOAc and used as the starting material to construct the SSH cDNA library. PCR select cDNA subtraction was conducted using PCR-Select™ cDNA Subtraction Kit (Clontech, USA) with 2 μg of mRNA for each sample as starting material according to the manufacturer’s instructions. Subtraction hybridization was conducted to perform subtraction in both forward and reverse directions. After two rounds of hybridization, PCR was conducted to selectively amplify cDNAs differentially expressed between ORFV-inoculated and normal MDBK cells. Each PCR amplification described below was conducted using a thermal cycler MyCycler (Bio-Rad) in a total volume of 25 μL with 1 μL template DNA, 0.5 U of 50 × Advantage cDNA polymerase (Clontech, USA), 200 μM of each dNTP, and forward and reverse primers (1 μM each). The cDNA fragments for subtracted secondary PCR products were inserted into the pMD18-T vector (TaKaRa, Dalian, China) with T4 DNA ligase and transformed into DH5a Escherichia coli cells. The clones with recombinant plasmid were identified by the LB-ampicillin/IPTG/X-Gal medium colony screening. Recombinant white clones were selected randomly and amplified by PCR using the M13 primer to construct the corresponding SSH cDNA library. The clones that yielded a single PCR product were selected for the next analysis.

qRT-PCR analysis of CypB expression in ORFV-infected MDBK cells

Among the differentially expressed genes obtained by SSH technique, CypB was found to be significantly up-regulated in the ORFV-infected MDBK cells at an early phase of infection. The qRT-PCR method based on the CypB gene was applied to determine the mRNA expression level of CypB in MDBK cells infected with ORFV-Jilin (MOI = 3) for 0 h, 2 h, 4 h, 8 h, 12 h, 18 h and 24 h. The primer sets used in the study were specific for CypB (forward primer 5′-GAGACGGCACTGGAGGTAAG-3′; reverse primer 5′-TCGTGATGAAGAACTGGGAG-3′). Briefly, total RNA was isolated from both mock- and ORFV-inoculated cell lysates using RNAiso Plus (Takara, Dalian, China) according to the manufacturer’s instructions. Then, 200 ng of each RNA sample was used in a Oligo (dT) cDNA synthesis. The qPCRs for CypB gene were performed in 20 μL of reaction mixture containing 10 μL SYBR Premix ExTaq (Takara, Dalian, China), 0.2 μM of each oligonucleotide primer, 100 ng of each cDNA sample, and 7.2 μL ddH2O. Each sample was repeated three times. Fluorescent signals were analyzed by an ABI PRISM 7000 (Applied Biosystems, Tokyo, Japan). Data were statistically analyzed by Student’s t-test using GraphPad Prism 6 software.

Western blotting analysis of CypB expression in ORFV-infected MDBK cells

The MDBK cells at hours 0, 2, 4, 8, 12, 18 and 24 post infection were washed thoroughly and lysed in cell lysis buffer (20 mM Tris [pH 7.5], 150 mM NaCl, 1% Triton X-100, sodium pyrophosphate, β-glycerophosphate, EDTA, Na3VO4, leupeptin). The lysates were briefly sonicated and cleared by centrifugation for 5 min at 12,000 g at 4 °C. The lysates were further denatured by incubation for 10 min at 95 °C in sample buffer (2% SDS, 10% glycerol, 50 mM Tris [pH 6.8], 5% β-mercaptoethanol, 0.01% bromophenol blue). The samples were then subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to polyvinylidene fluoride membranes (Millipore, Bedford, MA). After incubation in blocking buffer (5% nonfat milk powder in PBS) for 1 h at room temperature, the membrane was reacted with anti-Cyclophilin B antibody (1:1000) overnight at 4 °C and HRP-conjugated secondary antibodies (1:3000) for 1 h at 37 °C. The antibody-antigen complex was visualized by enhanced chemiluminescence (ECL) (Thermo Fisher Scientific).

Anti-ORFV activity of CsA in vitro detected by MTT assay

MTT assay used for measuring cell survival and proliferation was performed in order to determine the effect of CsA on the inhibitory ratio of ORFV. Briefly, a confluent monolayer of MDBK cells grown on 96-well plates were inocubated with ORFV-Jilin (MOI = 0.1) and incubated in a CO2 incubator with a 5% CO2 atmosphere. After 2 h of adsorption, the maintenance medium containing various concentrations of CsA (0.05, 0.1, 0.2, 0.4, 0.8, 1.6, 3.2 μg/mL) was added after removing the virus inoculum. At 24 h after drug action, 100 μL MTT (tetrazolium salt 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) were added to each well and kept in a dark environment for 4 h at 37 °C. Then, MTT was aspirated and 100 μL well−1 of DMSO (Merck, Darmstad, Germany) was added to each well. Subsequently, the absorbance value at a wavelength of 570 nm was measured using a UV–visible spectrophotometer (LPB Pharmacia, Bromma, Sweden) for the calculating the inhibitory rate of CsA on ORFV proliferation. The untreated cell cultures were cultured under the same conditions. Data were statistically analyzed by one-way ANOVA followed by Fisher’s least significant difference (LSD) test using GraphPad Prism 6 software.

CypB gene silencing by siRNA

Based on the sequences of CypB, two pairs of siRNAs, CypB-specific siRNA and negative siRNA control (scrambled siRNA) were designed and synthesized by Shanghai GenePharma Co., Ltd. The sequences are shown in Table 1. The cells were grown on 12-well plates and incubated in a CO2 incubator with a 5% CO2 atmosphere. Approximately 50–60% confluent, the cells were transfected with 35 nM siRNA by using X-tremeGENE siRNA transfection reagent (Roche, USA) according to the manufacturer’s protocol. The transfected cells were then washed with MEM without serum and incubated in MEM supplemented with 2% fetal bovine serum. Untransfected MDBK cells were used as a control. Typical siRNA transfection efficiency was found to be 83% for MDBK cells as monitored by fluorescein-labeled control siRNA duplex. CypB knockdown was confirmed 48 h post siRNA transfection by qRT-PCR and Western blotting (data not shown).
Table 1
List of siRNA sequences used in this study
Name
Primer Sequences (5′-3′)
CypB specific siRNA
up
GCAUCUACGGUGAACGCUUTT
down
AAGCGUUCACCGUAGAUGCTT
Negative control siRNA
up
UUCUCCGAACGUGUCACGUTT
down
ACGUGACACGUUCGGAGAATT

Immunofluorescence assay after siRNA knockdown of CypB

The MDBK cells were mock-transfected or transfected with CypB siRNAs or scrambled siRNAs for 48 h and subjected to immunofluorescence assay. Cells cultured on glass slides were washed gently in phosphate buffered saline (PBS), and fixed with 4% paraformaldehyde for 30 min, PBS washed (three times, each 5 min); 0.2% Triton X-100 enhanced the permeability of cell membranes for 10 min at room temperature and PBS washed; 5% skim milk incubated 1 h, PBS washed. Then cells were incubated with PE-Cy5 conjugated rabbit anti-Cyclophilin B antibody (1:500) at 4 °C over the night. Cell nuclei were stained blue with DAPI for 15 min. Finally, the samples were washed three times with PBS and observed under immunofluorescent microscope.

Effect of CypB gene silencing on ORFV replication

At 48 h post siRNA transfection, the siRNA-treated cells were infected with ORFV-Jilin (MOI = 3), respectively. Viral DNA was extracted from cell cultures at 12 h, 24 h, 36 h, 48 h, 60 h and 72 h postinfection. The qPCR method based on the DNA polymerase gene of ORFV was applied to determine the viral DNA copy number. The qPCR assay was performed as described previously [15]. Furthermore, viral yields were quantitated in the siRNA-treated cells by the 50% tissue culture infectious dose (TCID50) method. Briefly, the siRNA-treated cells were infected with 100 TCID50 (106.5) of ORFV, and the infection was allowed to proceed for the indicated time periods. Untransfected MDBK cells were used as a control. Data were statistically analyzed by one-way ANOVA followed by Fisher’s LSD test using GraphPad Prism 6 software.

Statistical analysis

Statistical analysis was carried out using GraphPad Prism v6.0 (GraphPad Software, La Jolla, CA). Student’s t-test and one-way ANOVA followed by Fisher’s LSD test were used for comparisons of two and multiple groups, respectively. Data were expressed as the means with error bars depicting ± SEM, and differences were considered statistically significant at * P < 0.05, ** P < 0.01, *** P < 0.001.

Results

CypB was found to be significantly up-regulated in the ORFV-infected MDBK cells by SSH technique

In order to explore host genes inovolved in the process of ORFV invasion, the differentially expressed genes from ORFV-infected MDBK cells at an early phase of infection were identified using SSH technique. A total of 81 expressed sequence tags (ESTs) were obtained from the SSH libraries by sequencing and alignment. Among of all the ESTs, 60 ESTs came from the forward SSH library and 21 ESTs came from the reverse SSH library. BLAST analysis against the Genbank database revealed that 79 ESTs showed significantly homology to known genes. Of those, all the ESTs showed significantly homology with Bos Taurus related sequences (Tables 2 and 3). CypB as an important member of cyclophilins family, was found to be significantly up-regulated in the ORFV-infected MDBK cells at an early phase of infection.
Table 2
Similarity between expressed sequence tags in the forward suppression subtractive hybridization library and genes in GenBank
EST No.
Species
Gene homology
Gene name
Fold upregulation
F-1
Bos Taurus
Bos taurus beta-actin (ACTB) mRNA
ACTB
1.5
F-2
Bos Taurus
Bos taurus actin, gamma 1 (ACTG1), mRNA
ACTG1
1.7
F-3
unknown
unknown
unknown
3.4
F-4
Bos Taurus
Bos taurus vacuole membrane protein 1 (VMP1), mRNA
VMP1
3.7
F-5
Bos Taurus
Bos taurus ring finger protein 19B (RNF19B), mRNA
RNF19B
1.9
F-6
Bos Taurus
Bos taurus zinc finger protein 408 (ZNF408), mRNA
ZNF408
2.3
F-7
Bos Taurus
Bos taurus zinc finger CCCH-type containing 14 (ZC3H14), transcript variant 1, mRNA
ZC3H14
1.5
F-8
Bos Taurus
Bos taurus ATPase, Na+/K+ transporting, beta 1 polypeptide (ATP1B1), mRNA.
ATP1B1
3.4
F-9
Bos Taurus
Bos taurus poly-U binding splicing factor 60KDa (PUF60), mRNA.
PUF60
2.3
F-10
unknown
unknown
unknown
2.6
F-11
Bos Taurus
Bos taurus eukaryotic translation initiation factor 3, subunit L (EIF3L), mRNA
EIF3L
3.7
F-12
Bos Taurus
Bos taurus eukaryotic translation elongation factor 1 alpha 1 EEF1A1), mRNA
EEF1A1
3.4
F-13
Bos Taurus
Bos taurus eukaryotic translation initiation factor 5 (EIF5), mRNA
EIF5
2.9
F-14
Bos Taurus
Bos taurus cytohesin 2 (CYTH2), mRNA
CYTH2
1.6
F-15
Bos Taurus
Bos taurus transmembrane emp24 protein transport domain containing 1 (TMED1), mRNA
TMED1
3.6
F-16
Bos Taurus
Bos taurus transmembrane protein 179B (TMEM179B), mRNA
TMEM179B
2.8
F-17
Bos Taurus
Bos taurus neuropilin 2 (NRP2), mRNA
NRP2
2.1
F-18
Bos Taurus
Sin3A-associated protein, 18 kDa (SAP18), mRNA
SAP18
2.4
F-19
Bos Taurus
Bos taurus renin binding protein (RENBP), mRNA
RENBP
1.3
F-20
Bos Taurus
Bos taurus signal sequence receptor, alpha (SSR1), mRNA
SSR1
1.9
F-21
Bos Taurus
Bos taurus mitogen-activated protein kinase kinase 6 (MAP2K6), mRNA
MAP2K6/MKK6
9.2
F-22
Bos Taurus
Bos Taurus solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 (SLC1A1), mRNA.
SLC1A1
2.7
F-23
Bos Taurus
Bos taurus isolate Mcg489 mitochondrion, complete genome
Mcg489 mitochondrion
2.5
F-24
Bos Taurus
Calmodulin 1 (phosphorylase kinase, delta) (CALM1), mRNA
CALM1
2.3
F-25
Bos Taurus
Bos taurus enhancer of rudimentary homolog (Drosophila) (ERH), mRNA
ERH
1.7
F-26
Bos Taurus
Bos taurus threonyl-tRNA synthetase-like 1 (TARSL1), mRNA, complete cds.
TARSL1
2.1
F-27
Bos Taurus
Bos taurus threonyl-tRNA synthetase 2, mitochondrial (putative) (TARS2), mRNA
TARS2
1.8
F-28
Bos Taurus
Bos taurus S100 calcium binding protein A2 (S100A2), mRNA
S100A2
9.7
F-29
Bos Taurus
Bos taurus lactate dehydrogenase B (LDHB), mRNA, complete cds.
LDHB
3.5
F-30
Bos Taurus
Bos taurus H3 histone, family 3A (H3F3A), mRNA.
H3F3A
4.2
F-31
Bos Taurus
Bos taurus heterogeneous nuclear ribonucleoprotein U (scaffold attachment factor A) (HNRNPU), mRNA.
HNRNPU
2.9
F-32
Bos Taurus
Bos taurus RAB2A, member RAS oncogene family (RAB2A), mRNA.
RAB2A
1.5
F-33
Bos Taurus
Bos taurus alanyl-tRNA synthetase (AARS), mRNA
AARS
1.9
F-34
Bos Taurus
Bos taurus minichromosome maintenance complex component 4 (MCM4), mRNA
MCM4
2.7
F-35
Bos Taurus
Bos taurus tubulin, beta 6, mRNA
TUBB6
1.3
F-36
Bos Taurus
Bos taurus tubulin, alpha 1c (TUBA1C), mRNA
TUBA1C
1.7
F-37
Bos Taurus
Bos taurus tubulin, alpha 1b (TUBA1B), mRNA
TUBA1B
1.2
F-38
Bos Taurus
Bos taurus tropomyosin 1 (alpha) (TPM1), mRNA
TPM1
2.0
F-39
Bos Taurus
Bos taurus tropomyosin 4 (TPM4), mRNA
TPM4
1.5
F-40
Bos Taurus
Bos taurus minichromosome maintenance complex component 6 (MCM6), mRNA
MCM6
2.3
F-41
Bos Taurus
Bos taurus chromosome 10 open reading frame, human C14orf1 (C10H14orf1), mRNA.
C10H14orf1
2.4
F-42
Bos Taurus
Bos taurus CLPTM1-like (CLPTM1L), mRNA
CLPTM1L
4.3
F-43
Bos Taurus
Bos taurus CD151 molecule (Raph blood group) (CD151), mRNA
CD151
7.6
F-44
Bos Taurus
Bos taurus ubiquinol-cytochrome c reductase binding protein (UQCRB), mRNA.
UQCRB
2.6
F-45
Bos Taurus
Bos taurus low molecular mass ubiquinone-binding protein mRNA, complete cds.
Low molecular mass ubiquinone-binding protein
2.1
F-46
Bos Taurus
Bos taurus dynein, cytoplasmic 1, light intermediate chain 1 (DYNC1LI1), mRNA
DYNC1LI1
3.5
F-47
Bos Taurus
Bos taurus glucose-6-phosphate isomerase (GPI), mRNA
GPI
2.9
F-48
Bos Taurus
Bos taurus galactosidase, beta 1 (GLB1), mRNA
GLB1
2.4
F-49
Bos Taurus
Bos taurus proteasome (prosome, macropain) activator subunit 1 (PA28 alpha) (PSME1), mRNA.
PSME1
1.3
F-50
Bos Taurus
Bos taurus peptidylprolyl isomerase B (cyclophilin B) (PPIB), mRNA
PPIB
10.2
F-51
Bos Taurus
Bos taurus peroxiredoxin 2 (PRDX2), mRNA.
PRDX2
3.4
F-52
Bos Taurus
Bos taurus proteolipid protein 2 (colonic epithelium-enriched) (PLP2), mRNA.
PLP2
3.7
F-53
Bos Taurus
Bos taurus voucher proven bull 27,223 mitochondrion, complete genome.
Bos taurus voucher proven bull 27,223 mitochondrion
2.1
F-54
Bos Taurus
Bos taurus Fas-activated serine/threonine kinase (FASTK), mRNA.
FASTK
4.6
F-55
Bos Taurus
Bos taurus ferritin, light polypeptide (FTL), mRNA
FTL
2.5
F-56
Bos Taurus
Bos taurus Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed (FAU), mRNA.
FAU
1.2
F-57
Bos Taurus
Bos taurus acyl-CoA thioesterase 7 (ACOT7), mRNA
ACOT7
1.9
F-58
Bos Taurus
Bos taurus adenine phosphoribosyltransferase (APRT), mRNA
APRT
1.5
F-59
Bos Taurus
Bos taurus mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase (MGAT1), mRNA, complete cds
MGAT1
1.7
F-60
Bos Taurus
Bos taurus lactate dehydrogenase C (LDHC), transcript variant 1, mRNA.
LDHC
2.3
Table 3
Similarity between expressed sequence tags in the rverse suppression subtractive hybridization library and genes in GenBank
EST No.
Species
Gene homology
Gene name
Fold downregulation
R-1
Bos Taurus
Bos taurus mitogen-activated protein kinase kinase 4 (MAP2K4), mRNA.
MAP2K4/MKK4
8.7
R-2
Bos Taurus
Bos taurus neuroplastin (NPTN), mRNA
NPTN
1.9
R-3
Bos Taurus
Bos taurus nuclear transport factor 2 (NUTF2), mRNA
NUTF2
2.5
R-4
Bos Taurus
Bos taurus S100 calcium binding protein A4 (S100A4), mRNA
S100A4
9.6
R-5
Bos Taurus
Bos taurus acyl-CoA synthetase long-chain family member 5 (ACSL5), mRNA, complete cds
ACSL5
2.9
R-6
Bos Taurus
Bos taurus eukaryotic translation elongation factor 2 (EEF2), mRNA
EEF2
3.8
R-7
Bos Taurus
Bos taurus poly-U binding splicing factor 60KDa (PUF60), mRNA
PUF60
1.3
R-8
Bos Taurus
Bos taurus H3 histone, family 3B (H3.3B) (H3F3B), mRNA
H3F3B
2.6
R-9
Bos Taurus
Bos taurus glyceraldehyde-3-phosphate dehydrogenase (GAPDH), mRNA
GAPDH
1.2
R-10
Bos Taurus
Bos taurus NADH dehydrogenase (ubiquinone) complex I, assembly factor 1 (NDUFAF1), mRNA
NDUFAF1
1.7
R-11
Bos Taurus
Bos taurus solute carrier family 51, beta subunit (SLC51B), mRNA
SLC51B
3.2
R-12
Bos Taurus
Bos taurus ferredoxin 1 (FDX1), mRNA
FDX1
2.5
R-13
Bos Taurus
Bos taurus transforming growth factor beta 1 induced transcript 1 (TGFB1I1), mRNA
TGFB1I1
1.4
R-14
Bos Taurus
Bos taurus heat shock 70 kDa protein 8 (HSPA8), mRNA
HSPA8
10.2
R-15
Bos Taurus
Bos taurus vimentin (VIM), mRNA
VIM
6.4
R-16
Bos Taurus
Bos taurus lectin, galactoside-binding, soluble, 1 (LGALS1), mRNA
LGALS1
2.1
R-17
Bos Taurus
Bos taurus clone IMAGE:7,961,517 NDP kinase NBR-A mRNA, complete cds
NDP kinase NBR-A
1.5
R-18
Bos Taurus
Bos taurus polymerase (RNA) I polypeptide D (POLR1D), mRNA
POLR1D
1.5
R-19
Bos Taurus
Bos taurus guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 (GNAI1), mRNA
GNAI1
1.2
R-20
Bos Taurus
Bos taurus annexin A2 (ANXA2), mRNA
ANXA2
1.9
R-21
Bos Taurus
Bos taurus Williams Beuren syndrome chromosome region 22 (WBSCR22), mRNA
WBSCR22
2.3

Verification of the mRNA expression levels of CypB gene by qRT-PCR

We further verified the mRNA expression levels of CypB gene by qRT-PCR (Fig. 1a). CypB was confirmed by qRT-PCR as differentially expressed. The transcript levels of CypB was overexpressed in MDBK cells infected with ORFV-Jilin compared with mock-infected MDBK cells (Fig. 1b), with CypB mRNA levels 106-fold higher in ORFV-infected MDBK cells at 4 h post infection than in the corresponding mock-infected MDBK cells.

Verification of the protein expression levels of CypB by Western blotting

The expression of CypB gene was confirmed by Western blotting using β-actin as an internal control. Western blot analysis showed increased expression in the ORFV-infected MDBK cells, especially at 4 h post infection (Fig. 2). The results were consistent with those obtained from qRT-PCR. These findings suggested that changes in the expression of CypB gene and protein are associated with ORFV early infection.

Inhibition effect of CsA on ORFV proliferation in MDBK cells

The inhibition of CsA on ORFV proliferation in vitro was evaluated by MTT assay. The MDBK cells infected with ORFV were exposed to increasing concentrations of CsA from 0 to 3.2 μg/mL and maximal ethanol concentration used to solubilize and dilute CsA as vehicle. As demonstrated in Fig. 3, the inhibition rate was increased in different concentrations of CsA (0.05, 0.1, 0.2, 0.4, 0.8, 1.6, 3.2 μg/mL) in comparision with the control (no treatment) and this increase was significant in 0.2 μg/mL (*** P < 0.001). Our results showed that treatment with 0.2 μg/mL CsA could effectively inhibit the cytotoxicity induced by ORFV.

Examination of siRNA effect by Immunofluorescence assay

The immunofluorescence assay was performed in order to determine the inhibitory effect of CypB specific siRNAs. As shown in Fig. 4, the CypB-specific red fluorescence signals distributed in the cytoplasm of MDBK cells was found to be attenuated at 48 h post transfection. The cells transfected with scrambled siRNAs exhibited relative apparent fluorescent signals, which was similar to that in mock-transfected cells. However, no red fluorescence signals were observed in the cells transfected with CypB specific siRNAs. Nuclei were stained blue with DAPI.

Examination of siRNA effect by qPCR

To quantify the effect of siRNA on viral replication, the viral genome copy number was determined at 12 h, 24 h, 36 h, 48 h, 60 h and 72 h postinfection by qPCR based on the DNA polymerase gene of ORFV. The results indicated a marked reduction in the relative expression level of viral genome copies, compared to the mock group at 12 h, 24 h, 36 h, 48 h, 60 h and 72 h postinfection, when the CypB specific siRNA were used. At 48 h postinfection, the number of viral genome copies of the siRNA-treated cells was only 1 % in the ORFV-infected cells (Fig. 5a).

Examination of siRNA effect by infectious virus assay

To further investigate the inhibitory effect of siRNAs, the microtiter method was used for titration of ORFV at 5 days postinfection. The results (Fig. 5b) showed that viral titers in untransfected MDBK cells was higher than in the siRNA-treated cells at 12 h, 24 h, 36 h, 48 h, 60 h and 72 h postinfection. In untransfected MDBK cells, titers reached a peak of around 1 × 106.3/0.1 mL (TCID50) at 60 h postinfection, however, titers reached similar values in the siRNA-treated cells at 72 h postinfection.

Discussion

Viruses are strict intracellular pathogens that require the cellular environment to complete a successful infection. During the infection process, viruses could affect several major cellular responses by altering the expression of the key host genes. Considering viral infection strongly relies on several factors from the host, the study of virus-host interactions is essential to the understanding of the infection process of disease and the mechanism of the virus persistence in the host, and to help with the development of effective vaccines and perhaps the cure of viral infections.
ORFV is a highly epitheliotropic virus, that infects damaged or scarified skin and replicates in regenerating epidermal keratinocytes. An important characteristic of the virus is its ability to cause repeated and persistent infections [16] even in the presence of an intensive inflammatory and multiple host immune response [3, 17]. At present, little is known about the mechanisms of ORFV infection of host, although several studies have demonstrated that ORFV encoded protein might interact with a host protein involved in the pathway and/or might mimic the structurally similar host protein to invade/manipulate the cellular pathway [18, 19].
With the purpose of identify genes involved in ORFV early invasion, we constructed a cDNA library and identified the differently expressed genes from ORFV-infected MDBK cells at an early phase of infection in the study. By using SSH technique, a total of 81 EST sequences with differing functions were identified, including 60 differently up-regulated genes from the forward library and 21 differently down-regulated genes from the reverse library. CypB as an important member of cyclophilins family, was found to be significantly up-regulated in the ORFV-infected MDBK cells at an early phase of infection. In the present study, the upregulation of CypB in host cells was further validated by qRT-PCR and Western blotting. The results showed that CypB was overexpressed in MDBK cells infected with ORFV-Jilin at 4 h post infection, which were consistent with those obtained by SSH technique.
Recently, increasing studies have demonstrated that cellular CypB are closely related with viral infections such as JEV [11], HCV [12] and HPV 16 [13]. However, the role of CypB in ORFV proliferation have remained unknown. By using CsA, we determined that it could effectively inhibit the cytotoxicity induced by ORFV, which suggested that CypB was required for the efficient proliferation of ORFV in vitro. To further ascertain the regulatory role of CypB for ORFV replication, CypB specific siRNAs were synthesized and then transfected. The efficiency of inhibition of viral replication was evaluated by immunofluorescence assay, qPCR and infectious virus assay. The results demonstrated that silencing of CypB gene by RNAi could efficiently inhibit ORFV genome replication and infectious virus production. On the basis of the above studies, CypB has been confirmed to facilitate ORFV replication.
Moreover, CypB has been demonstrated to involve in inflammatory events [20]. The overexpressed CypB could activate the extracellular signal-regulated kinase intracellular signaling pathway such as ERK signaling through binding with CD147, which has been shown to function as a signalling receptor for CypB to mediate chemotactic activity towards a variety of immune cells [2123]. Currently, the upregulation of CypB has been confirmed to facilitate ORFV replication, presumably through interactions with CD147 or other some agents to activate the associated immunological and inflammatory signaling pathways. Further investigations on the cooperation between these molecules might provide new insights on the mechanisms controlling ORFV infection within target cells and lead to the development of new therapeutic tools to block the virus infection.

Conclusions

The results of the present study demonstrated that CypB could effectively facilitate the replication of ORFV, suggesting CypB might be involved in the process of ORFV infection. However, the detailed interaction between CypB and ORFV is still unknown. Further studies will be focused on the interplay between ORFV and cellular CypB, which may contribute to clarify virus pathogenesis and the development of antiviral vaccine candidates and novel inhibitors.

Acknowledgements

Financial support for this study was obtained from the National Natural Science Foundation of China (Grant number 31672554), the Key scientific and technological project of Jilin Province (Grant number 20140204076NY), the Funding of world bank financed project of Jilin Province (Grant number 2011-Y20), and the program Supported by Jilin University for the Excellent Youth Scholars (Grant number 419080500593).

Funding

National Natural Science Foundation of China (31672554), Key scientific and technological project of Jilin Province (20140204076NY), Funding of world bank financed project of Jilin Province (2011-Y20) and the program Supported by Jilin University for the Excellent Youth Scholars (419080500593).

Availability of data and materials

All data generated or analyzed during the study are included in this study.

Authors’ contributions

KZ and FG conceived the study and participated in its design and coordination. JL, XZ, YZ and DZ performed the experiments. KZ, WH and DS analyzed the data and wrote the paper. All authors read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interests.
Not applicable.
This article does not contain any studies with human participants or animals performed by any of the authors.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.
Literatur
1.
Zurück zum Zitat Chan KW, Lin JW, Lee SH, Liao CJ, Tsai MC, Hsu WL, et al. Identification and phylogenetic analysis of orf virus from goats in Taiwan. Virus Genes. 2007;35(3):705–12.CrossRefPubMed Chan KW, Lin JW, Lee SH, Liao CJ, Tsai MC, Hsu WL, et al. Identification and phylogenetic analysis of orf virus from goats in Taiwan. Virus Genes. 2007;35(3):705–12.CrossRefPubMed
2.
Zurück zum Zitat Hosamani M, Scagliarini A, Bhanuprakash V, McInnes CJ, Singh RK. Orf: an update on current research and future perspectives. Expert Rev Antiinfect Ther. 2009;7:879–93.CrossRef Hosamani M, Scagliarini A, Bhanuprakash V, McInnes CJ, Singh RK. Orf: an update on current research and future perspectives. Expert Rev Antiinfect Ther. 2009;7:879–93.CrossRef
3.
Zurück zum Zitat Haig DM, McInnes CJ. Immunity and counter-immunity during infection with the parapoxvirus orf virus. Virus Res. 2002;88:3–16.CrossRefPubMed Haig DM, McInnes CJ. Immunity and counter-immunity during infection with the parapoxvirus orf virus. Virus Res. 2002;88:3–16.CrossRefPubMed
4.
Zurück zum Zitat Handschumacher RE, Harding MW, Rice J, Drugge RJ, Speicher DW. Cyclophilin: a specific cytosolic binding protein for cyclosporin A. Science. 1984;226:544–7.CrossRefPubMed Handschumacher RE, Harding MW, Rice J, Drugge RJ, Speicher DW. Cyclophilin: a specific cytosolic binding protein for cyclosporin A. Science. 1984;226:544–7.CrossRefPubMed
5.
Zurück zum Zitat Schreiber SL. Chemistry and biology of the immunophilins and their immunosuppressive ligands. Science. 1991;251:283–7.CrossRefPubMed Schreiber SL. Chemistry and biology of the immunophilins and their immunosuppressive ligands. Science. 1991;251:283–7.CrossRefPubMed
6.
Zurück zum Zitat Price ER, Jin M, Lim D, Pati S, Walsh CT, Mckeon FD. Cyclophilin B trafficking through the secretory pathway is altered by binding of cyclosporin A. Proc Natl Acad Sci U S A. 1994;91(9):3931–5.CrossRefPubMedPubMedCentral Price ER, Jin M, Lim D, Pati S, Walsh CT, Mckeon FD. Cyclophilin B trafficking through the secretory pathway is altered by binding of cyclosporin A. Proc Natl Acad Sci U S A. 1994;91(9):3931–5.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Rycyzyn MA, Clevenger CV. The intranuclear prolactin/cyclophilin B complex as a transcriptional inducer. Proc Natl Acad Sci U S A. 2002;99(10):6790–5.CrossRefPubMedPubMedCentral Rycyzyn MA, Clevenger CV. The intranuclear prolactin/cyclophilin B complex as a transcriptional inducer. Proc Natl Acad Sci U S A. 2002;99(10):6790–5.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Allain F, Denys A, Spik G. Cyclophilin B mediates cyclosporin A incorporation in human blood T-lymphocytes through the specific binding of complexed drug to the cell surface. Biochem J. 1996;317(Pt 2):565–70.CrossRefPubMedPubMedCentral Allain F, Denys A, Spik G. Cyclophilin B mediates cyclosporin A incorporation in human blood T-lymphocytes through the specific binding of complexed drug to the cell surface. Biochem J. 1996;317(Pt 2):565–70.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Kim J, Choi TG, Ding Y, Kim Y, Ha KS, Lee KH, et al. Overexpressed cyclophilin B suppresses apoptosis associated with ROS and Ca2+ homeostasis after ER stress. J Cell Sci. 2008;121(Pt 21):3636–48.CrossRefPubMedPubMedCentral Kim J, Choi TG, Ding Y, Kim Y, Ha KS, Lee KH, et al. Overexpressed cyclophilin B suppresses apoptosis associated with ROS and Ca2+ homeostasis after ER stress. J Cell Sci. 2008;121(Pt 21):3636–48.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Kambara H, Tani H, Mori Y, Abe T, Katoh H, Fukubara T, et al. Involvement of cyclophilin B in the replication of Japanese encephalitis virus. Virology. 2011;412:211–9.CrossRefPubMed Kambara H, Tani H, Mori Y, Abe T, Katoh H, Fukubara T, et al. Involvement of cyclophilin B in the replication of Japanese encephalitis virus. Virology. 2011;412:211–9.CrossRefPubMed
12.
Zurück zum Zitat Watashi K, Ishii N, Hijikata M, Inoue D, Murata T, Miyanari Y, et al. Cyclophilin B is a functional regulator of Hepatitis C virus RNA polymerase. Mol Cell. 2005;19:111–22.CrossRefPubMed Watashi K, Ishii N, Hijikata M, Inoue D, Murata T, Miyanari Y, et al. Cyclophilin B is a functional regulator of Hepatitis C virus RNA polymerase. Mol Cell. 2005;19:111–22.CrossRefPubMed
13.
Zurück zum Zitat Bienkowska-Haba M, Patel HD, Sapp M. Target cell cyclophilins facilitate human papillomavirus type 16 infection. PLoS Pathog. 2009;5(7):e1000524.CrossRefPubMedPubMedCentral Bienkowska-Haba M, Patel HD, Sapp M. Target cell cyclophilins facilitate human papillomavirus type 16 infection. PLoS Pathog. 2009;5(7):e1000524.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Zhao K, Song D, He W, Lu H, Zhang B, Li C, et al. Identification and phylogenetic analysis of an Orf virus isolated from an outbreak in sheep in the Jilin province of China. Vet Microbiol. 2010;142:408–15.CrossRefPubMed Zhao K, Song D, He W, Lu H, Zhang B, Li C, et al. Identification and phylogenetic analysis of an Orf virus isolated from an outbreak in sheep in the Jilin province of China. Vet Microbiol. 2010;142:408–15.CrossRefPubMed
15.
Zurück zum Zitat Li J, Song D, He W, Bao Y, Lu R, Su G, et al. Rapid detection of orf virus by loop-mediated isothermal amplification based on the DNA polymerase gene. Arch Virol. 2013;158:793–8.CrossRefPubMed Li J, Song D, He W, Bao Y, Lu R, Su G, et al. Rapid detection of orf virus by loop-mediated isothermal amplification based on the DNA polymerase gene. Arch Virol. 2013;158:793–8.CrossRefPubMed
16.
Zurück zum Zitat Ndikuwera J, Odiawo GO, Usenik EA, Kock ND, Ogaa JS, Kuiper R. Chronic contagious ecthyma and caseous lymphadenitis in two Boer goats. Vet Rec. 1992;131(25–26):584–5.PubMed Ndikuwera J, Odiawo GO, Usenik EA, Kock ND, Ogaa JS, Kuiper R. Chronic contagious ecthyma and caseous lymphadenitis in two Boer goats. Vet Rec. 1992;131(25–26):584–5.PubMed
17.
Zurück zum Zitat Diel DG, Delhon G, Luo S, Flores EF, Rock DL. A novel inhibitor of the NF-{kappa}B signaling pathway encoded by the parapoxvirus orf virus. J Virol. 2010;84:3962–73.CrossRefPubMedPubMedCentral Diel DG, Delhon G, Luo S, Flores EF, Rock DL. A novel inhibitor of the NF-{kappa}B signaling pathway encoded by the parapoxvirus orf virus. J Virol. 2010;84:3962–73.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Deane DL, McInnes CJ, Percival A, Wood A, Thomson J, Lear A, et al. Orf virus encodes a novel secreted protein inhibitor of granulocyte-macrophage clony-stimulating factor and interleukin-2. J Virol. 2000;74:1313–20.CrossRefPubMedPubMedCentral Deane DL, McInnes CJ, Percival A, Wood A, Thomson J, Lear A, et al. Orf virus encodes a novel secreted protein inhibitor of granulocyte-macrophage clony-stimulating factor and interleukin-2. J Virol. 2000;74:1313–20.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Fleming SB, Haig DM, Nettleton P, Reid HW, McCaughan CA, Wise LM, et al. Sequence and functional analysis of a homolog of interleukin-10 encoded by the parapoxvirus orf virus. Virus Genes. 2000;21:85–95.CrossRefPubMed Fleming SB, Haig DM, Nettleton P, Reid HW, McCaughan CA, Wise LM, et al. Sequence and functional analysis of a homolog of interleukin-10 encoded by the parapoxvirus orf virus. Virus Genes. 2000;21:85–95.CrossRefPubMed
20.
Zurück zum Zitat Arora K, Gwinn WM, Bower MA, Watson A, Okwumabua I, MacDonald HR, et al. Extracellular cyclophilins contribute to the regulation of inflammatory responses. J Immunol. 2005;175(1):517–22.CrossRefPubMedPubMedCentral Arora K, Gwinn WM, Bower MA, Watson A, Okwumabua I, MacDonald HR, et al. Extracellular cyclophilins contribute to the regulation of inflammatory responses. J Immunol. 2005;175(1):517–22.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Kim K, Kim H, Jeong K, Jung MH, Hahn BS, Yoon KS, et al. Release of overexpressed CypB activates ERK signaling through CD147 binding for hepatoma cell resistance to oxidative stress. Apoptosis. 2012;17(8):784–96.CrossRefPubMed Kim K, Kim H, Jeong K, Jung MH, Hahn BS, Yoon KS, et al. Release of overexpressed CypB activates ERK signaling through CD147 binding for hepatoma cell resistance to oxidative stress. Apoptosis. 2012;17(8):784–96.CrossRefPubMed
22.
Zurück zum Zitat Yurchenko V, O'Connor M, Dai WW, Guo H, Toole B, Sherry B, et al. CD147 is a signaling receptor for cyclophilin B. Biochem Biophys Res Commun. 2001;288(4):786–8.CrossRefPubMed Yurchenko V, O'Connor M, Dai WW, Guo H, Toole B, Sherry B, et al. CD147 is a signaling receptor for cyclophilin B. Biochem Biophys Res Commun. 2001;288(4):786–8.CrossRefPubMed
23.
Zurück zum Zitat Yurchenko V, Constant S, Eisenmesser E, Bukrinsky M. Cyclophilin-CD147 interactions: a new target for anti-inflammatory therapeutics. Clin Exp Immunol. 2010;160(3):305–17.CrossRefPubMedPubMedCentral Yurchenko V, Constant S, Eisenmesser E, Bukrinsky M. Cyclophilin-CD147 interactions: a new target for anti-inflammatory therapeutics. Clin Exp Immunol. 2010;160(3):305–17.CrossRefPubMedPubMedCentral
Metadaten
Titel
Cyclophilin B facilitates the replication of Orf virus
verfasst von
Kui Zhao
Jida Li
Wenqi He
Deguang Song
Ximu Zhang
Di Zhang
Yanlong Zhou
Feng Gao
Publikationsdatum
01.12.2017
Verlag
BioMed Central
Erschienen in
Virology Journal / Ausgabe 1/2017
Elektronische ISSN: 1743-422X
DOI
https://doi.org/10.1186/s12985-017-0781-x

Weitere Artikel der Ausgabe 1/2017

Virology Journal 1/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.